On Jan 5, 2022 AvengeBio closed a Series A round and raised $45,000,000 from CAM Capital, Longitude Capital, Pappas Capital, Perceptive Advisors, Rock Springs Capital, featuring lead investors CAM Capital, Perceptive Advisors.
About the company: AvengeBio is located at United States, North America.
“”
Company website: http://www.avengebio.com